Export 5 results:
Author Title [ Type(Asc)] Year
Filters: Author is Doody, Rachelle S  [Clear All Filters]
Journal Article
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., Validation of the Spanish version of the Baylor Profound Mental Status Examination., J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
S. Nave, Doody, R. S., Boada, M., Grimmer, T., Savola, J. - M., Delmar, P., Pauly-Evers, M., Nikolcheva, T., Czech, C., Borroni, E., Ricci, B., Dukart, J., Mannino, M., Carey, T., Moran, E., Gilaberte, I., Muelhardt, N. Milani, Gerlach, I., Santarelli, L., Ostrowitzki, S., and Fontoura, P., Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)., J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
K. Li, Chan, W., Doody, R. S., Quinn, J., and Luo, S., Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data., J Alzheimers Dis, vol. 58, no. 2, pp. 361-371, 2017.
R. S. Doody, Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., and Mohs, R., Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
J. Jia, Wei, C., Jia, L., Tang, Y., Liang, J., Zhou, A., Li, F., Shi, L., and Doody, R. S., Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial., J Alzheimers Dis, vol. 56, no. 4, pp. 1495-1504, 2017.